Global Survey Reports Perceived Disparities in Diabetes Drug Access Tags Rapid acting short acting Long acting α-Glucosidase inhibitors SGLT-2 Inhibitor Read more about Global Survey Reports Perceived Disparities in Diabetes Drug Access
Meta-Analysis of 42 RCTs Compares Safety of SGLT2 Inhibitors and DPP-4 Inhibitors in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about Meta-Analysis of 42 RCTs Compares Safety of SGLT2 Inhibitors and DPP-4 Inhibitors in Type 2 Diabetes
Ertugliflozin Associated With Higher DKA Risk Compared With Sulfonylureas or Thiazolidinediones and Incretin-Based Drugs Tags Diabetic ketoacidosis SGLT-2 Inhibitor Read more about Ertugliflozin Associated With Higher DKA Risk Compared With Sulfonylureas or Thiazolidinediones and Incretin-Based Drugs
Real-Time CGM May Significantly Improve Glycemic Control Across T2D Treatment Strategies Tags SCREENING GTT SGLT-2 Inhibitor Read more about Real-Time CGM May Significantly Improve Glycemic Control Across T2D Treatment Strategies
SGLT2 Inhibitors Linked to Lower Prostate Cancer Risk Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Linked to Lower Prostate Cancer Risk
Metformin Matches Empagliflozin in CKD Progression Retardation Tags Diabetic Nephropathy Diabetic Nephropathy SGLT-2 Inhibitor Read more about Metformin Matches Empagliflozin in CKD Progression Retardation
SGLT2 Inhibitors Make HbA1c Look Worse Than Reality Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Make HbA1c Look Worse Than Reality
Gender and Wealth Gaps Widen Type 2 Diabetes Crisis in China Tags α-Glucosidase inhibitors SGLT-2 Inhibitor Read more about Gender and Wealth Gaps Widen Type 2 Diabetes Crisis in China
SGLT2 Inhibitors Edge Out GLP-1s for Diabetic Foot Risks Tags Diabetic Neuropathy Diabetic foot. SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Edge Out GLP-1s for Diabetic Foot Risks
SGLT2 Drugs Boost Hemoglobin Even with Ongoing Inflammation Tags SGLT-2 Inhibitor Read more about SGLT2 Drugs Boost Hemoglobin Even with Ongoing Inflammation